Cite
HARVARD Citation
Chee, C. et al. (2013). Phase II Study of Dasatinib (BMS‐354825) in Patients With Metastatic Adenocarcinoma of the Pancreas. Oncologist. pp. 1091-1092. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chee, C. et al. (2013). Phase II Study of Dasatinib (BMS‐354825) in Patients With Metastatic Adenocarcinoma of the Pancreas. Oncologist. pp. 1091-1092. [Online].